In vivo-directed evolution identifies AAV-WM04 as a next-generation vector for potent and sustained hearing restoration in DFNB9
Yong Tao(Shanghai Ninth People's Hospital), H Wu(Shanghai Jiao Tong University), Cenfeng Chu(ShanghaiTech University), Zhenzhe Cheng(Shanghai Jiao Tong University), H Steve Zhang(Huazhong Agricultural University), Xuegao Mao(Shanghai Huayi Group (China)), Qiuxiang Yang(ShanghaiTech University), Guisheng Zhong(ShanghaiTech University), Yilin Sun(Shanghai Ninth People's Hospital), Boyu Yang(Beijing Technology and Business University), Yuehua Chen(Harbin Institute of Technology), Qifang Zhou(ShanghaiTech University), Zhuo Duan(ShanghaiTech University), Yao Lu(Shanghai Huayi Group (China)), Chenxi Jin(Shanghai Ninth People's Hospital), Shuyue Bao(Shanghai Ninth People's Hospital), Xianyu Huang(Shanghai Huayi Group (China)), Shan Yin(Shanghai Huayi Group (China)), Baoyi Feng(Shanghai Jiao Tong University)
Cited by 0
Related Papers
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
|Nature|2017|547
Stress-Induced Metabolic Disorder in Peripheral CD4+ T Cells Leads to Anxiety-like Behavior
|Cell|2019|323
Phage-assisted evolution and protein engineering yield compact, efficient prime editors
|Cell|2023|302
AAV-ie enables safe and efficient gene transfer to inner ear cells
|Nature Communications|2019|228